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Because the focus of nasopharyngeal carcinoma (NPC) is very close to intracranial organs, it often makes incursions into cranial cavity.
Identification of intracranial invasion-associated indicators will provide potential therapeutic targets for NPC patients with intracranial
invasion. In this regard, Human Xprot HC-plus cancer-related gene chip was utilised to screen intracranial invasion-associated genes
for NPC from the biopsied primary focus tissue samples. In all, 8 upregulated and 23 downregulated genes were obtained. VEGF165
and MMP-9, the two upregulated genes, and NM23-H1, the downregulated one, were further confirmed by immunohistochemistry,
quantitative real-time PCR and western blot. Invasion-associated cellular and nude mouse models were subsequently employed to
study the biological properties of NM23-H1. NM23-H1 expression was significantly lower in 5-8F cells compared with that in 6-10B
cells. Moreover, patch-clamp and transwell chamber were adopted to investigate the invading potential-associated biological dynamic
mechanisms in the two cell lines, and Ca
2þ current and motility were significantly elevated in 5-8F cells compared with that in 6-10B
cells. Berberine, an inhibitor of Ca
2þ current, could substantially increase the expression of NM23-H1 and decrease 5-8F cell motility.
The specificity of berberine on NM23-H1 and cell motility was confirmed by RNAi assay.
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Nasopharyngeal carcinoma (NPC) is the most common epithelial
malignant neoplasm in the nasopharynx, especially in Southern
China. Because of its close location to the intracranial organs,
cranial cavity invasion and metastasis that lead to poor prognosis
are commonly observed in clinical practice. Therefore, a better
understanding of molecular mechanisms involving in NPC
intracranial invasion and metastasis may lead to more effective
treatment of NPC patients.
Recently, gene-expression profiles provide more important
information about cancerous molecular biology and were used to
explore candidate biomarkers and identify groups of genes
involved in tumorigenesis. Several gene-expressing profiling
procedures have been applied to the various studies of NPC (Nie
et al, 2003; Sung et al, 2007; Zeng et al, 2007). These studies have
provided important information and led to the discovery of a
number of genes useful for laboratory research for NPC detection,
diagnosis and treatment. However, no gene-expressing profile
studies have been involved in intracranial invasion, and metas-
tasis-related genes in NPC tissue samples taken from the primary
focus in the nasopharynx.
Nucleoside diphosphate kinases, a highly conserved family in
eukaryotes, are encoded by NM23 genes. NM23-H1-8 has been
identified in human (Lacombe et al,1 9 9 3 ) .N M 2 3 - H 1c a t a l y s e st h e
phosphorylation of nucleoside 50-diphosphates to triphosphates
through a ‘ping-pong’ mechanism involving a high-energy phos-
phorylated enzyme intermediate, thus equilibrating the cellular pool
of NDP and NTP (Lascu and Gonin, 2000). NM23-H1 was identified
by Steeg et al (1988a,b), based on its low expression in metastatic
cells. Since then, low expression or mutation of NM23-H1 has been
implicated in cancer prognosis or metastasis in a variety of tumours
and malignant transformation (Leone et al, 1991; Yih et al, 2002; Fan
et al, 2003; Zhao and Li, 2004; Ma et al, 2005). However, it is still
unclear whether NM23-H1 expression is decreased or not and
whether it is associated with NPC intracranial Invasion.
In the present study, we used human cancer-relating gene chip
to determine the differences in gene expression between NPCs
from the primary nasopharyngeal focuses with and without
intracranial invasion and identified a number of differentially
expressed genes, including NM23-H1, that might be involved in
the intracranial invasion of NPC. Then, we adopted invasion-
associated cellular and nude mouse models to study the role of
NM23-H1 in NPC cell migration and metastasis.
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Patients and tissue samples of tumour
The primary focus tissue samples of NPC were obtained from NPC
patients in Hunan Provincial Tumor Hospital (Changsha, China),
including tissue specimens taken from NPC patients with
intracranial invasion (seven men and three women; age ranged
from 20 to 63 years) and without invasion (seven men and three
women; age ranged from 20 to 63 years). All the patients were first
diagnosed in this hospital without treatment. They did not have a
familial history of NPC. There were no significant statistic
differences in the distribution of gender and age in this group of
cases (Table 1). The cases with intracranial invasion from the
lesion were diagnosed by magnetic resonance imaging (Ng et al,
1997). All patients underwent endoscopies for medical reasons and
gave informed consent to take part in the study. This study was
carried out with ethical committee approval. The tissue specimens
from the primary focus (confirmed pathohistologically as squa-
mous cell carcinoma) were snap frozen in liquid nitrogen and
underwent blinded analysis (preparations for gene chip and gene
chip results analysis).
Gene-expression profiling
The differentially expressed genes related to NPC intracranial
invasion or metastasis potential were screened with Human Xprot
HC-plus cancer-relating gene chip of oligonucleotide (2748 cancer-
relating genes; National Engineering Research Center for Minia-
turized Detection System, Xian, China). The experimental
procedures were carried out in a comparative way between groups
of biopsies from the primary nasopharyngeal focus without
invasion or metastasis and those with intracranial invasion. Total
RNA was reverse transcribed with Cy3-labelled deoxyuridine
triphosphate incorporation and fluorescence quantified using a
Gene Pix 4000A Microarray Scanner (Gene Pix Pro 3.0 software;
Axon Instruments Inc., Union, CA, USA). The gene-expressing
profiling has been repeated three times for each group, and six
chips have been performed for the 20 patients. Subsequent analysis
was conducted by Spotfire 8.0 software.
Animals, agents and antibody
Animal experiments were performed in accordance with the
regulations of our institution’s ethics commission and with the
United Kingdom Co-ordinating Committee on Cancer Research
guidelines (Workman et al, 1998). Six-week-old male BALB/c nude
mice were purchased from the Institute of Laboratory Animal
Science, Chinese Academy of Medical Science. Berberine was
obtained from Sigma (St Louis, MO, USA). Mouse monoclonal
antibody for NM23-H1 and MMP-9 were from Maxin, Fuzhou,
China and rabbit polyclonal antibody for VEGF165 was from Santa
Cruz, California, USA.
Tumour cell lines and transfection
Human NPC cell lines 5-8F and 6-10B (established by Oncology
Institute of Sun Yat-sen University Cancer Center) were grown in
RPMI 1640 (Gibco, BRL, USA) supplemented with 10% fetal calf
serum (Sigma). Cells were transfected with Lipofectaminet 2000
(Invitrogen, California, USA) according to the manufacturer’s
instructions.
siRNA experiment
Hairpin loop constructs that produce specific small-interfering
RNAs (siRNAs; siNM23-H1 in text and figures) were designed and
constructed by targeting GGAGAUCGGCUUGUGGUUU and
GCUUCCGAAGAUCUUCUCA, two corresponding coding regions
of human NM23-H1 and a nonspecific control siRNA
GCGCGGGGCACGUUGGUGU (Yao et al, 2005). Annealed oligo-
nucleotides were cloned into the BamHI/EcoRI site of RNAi-Ready
pSIREN-RetroQ-ZsGreen (BD Biosciences, Palo Alto, CA, USA). 5-
8F cells (2 10
5 cells per well) were plated the day before
transfection.
Quantitative real-time PCR
Total RNA was extracted from the tissue samples using the Quick
Prep Total RNA Extraction Kit (Qiagen, Valencia, CA, USA). Total
RNA (1mg) was reverse transcribed using Oligo (dT)18 Primer and
SuperScriptt III (Invitrogen) to synthesise complementary DNA
(cDNA) following standard protocols. Transcriptional level was
quantified by quantitative real-time PCR using the Syber Green
PCR MASTER MIX kit (Applied Biosystems, Foster City, CA,
USA). Amplification and detection were performed with ABI
PRISM 7300 Sequence Detection System starting with 1mlo f
cDNA. The following primers and probes were used NM23-H1,
CCGGAGTTCAAACCTAAGCA and AGTTCCTCAGGGTGAAAC-
CA; VEGF165: ACTTTCTGCTGTCTTGGGTG and CATCTGCAAG-
TACGTTCGTTT; and MMP-9: ACCTTCACTCGCGTGTACAGC
and GCGGAGTAGGATTGGCCTTG. Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) was used as internal control. For relative
quantification, the copy ratios of NM23-H1/GAPDH, VEGF165/
GAPDH and MMP-9/GAPDH were calculated and shown as
indication of relative expression levels.
Western blot and immunohistochemistry
Western blot and immunohistochemical staining were performed
as described previously (Xu et al, 2001) and following the
manufacturer’s protocols (BD Biosciences), respectively.
XTT cytotoxicity assay
The cytotoxic effect of berberine on 5-8F, 6-10B and siNM23-H1-
transfected 5-8F cells was detected using proliferation kit (XTT II;
Boehringer, Mannheim, Germany). Briefly, cells were plated in 96-
well culture plates at a density of 5 10
4 cells per well and allowed
to attach for 2h. Berberine was added at various final concentra-
tions (0.35, 0.7, 1.4, 2.8, 5.6, 11.2 and 22.4mgml
 1) in quad-
ruplicate. After 24, 36, 72 and 96h, 100ml of XTT reaction solution
was added (Iizuka et al, 2000). Optical density was read at a
wavelength of 490nm in ELISA plate reader 4h later.
Cell migration and invasion assays
The invasion and migration activity of 5-8F, 6-10B and siNM23-
H1-transfected 5-8F cells was assayed using a transwell cell culture
chamber as described before (Albini et al, 1987). Cells were added
to transwell chamber (pore size, 12.0mm; CorningNY, Corning,
NY, USA). The number of cells that migrated through the
Table 1 Distribution of gender and age in NPC patients
Average ages
Gender
Groups No. of patients Age ranges (x ¯±s) Male Female
1 10 20–63 37±37 3
2 10 20–63 35±5* 7 3
NPC¼nasopharyngeal carcinoma. Note: Group 1, NPC patients with intracranial
invasion; group 2, NPC patients without invasion. *P40.05 compared with group 1.
NM23-H1 related with intracranial invasion
SJ Liu et al
364
British Journal of Cancer (2008) 98(2), 363–369 & 2008 Cancer Research UK
T
r
a
n
s
l
a
t
i
o
n
a
l
T
h
e
r
a
p
e
u
t
i
c
smembrane was counted 72h later. For transfection experiments,
cells were seeded 24h after transfection. For the invasion assays,
matrigel (BD Biosciences) was added to the transwell chambers
and incubated for 5h before cells were seeded. The number of
membrane-penetrating cells was counted 72h later. The migration
and the invasion assays were performed in quadruplicate for each
cell line tested.
Electrophysiological measurements
Patch-clamp experiments were performed in tight-seal whole-cell
configuration at room temperature in a standard bath solution
(Wu et al, 1998; Li et al, 2000). Patch-clamp experiments were
recorded with a computer-controlled patch clamp amplifier
(Axon). Capacitance and series resistance were calculated with
the software-supported internal routines of the Pclamp 8.1 and
compensated before each experiment. The voltage-depending
calcium electrical current (ICa) voltage clamp scheme was square
wave, with 30 and  90mV of voltage, 200ms of wave width, 10s of
stimulus interval,  90 to þ30mV of command potential and
20mV of step level pulse. The Ca
2þ-releasing activated Ca
2þ
current (ICRAC) voltage clamp scheme was square wave, with 0mV
of potential, 200ms of wave width, 20s of stimulus interval,  120
to þ60mV of command potential and 20mV of step level pulse.
Antimetastasis effect of berberine on aggressive NPC in
nude mouse model
Forty nude mice were randomly divided into four groups as shown
in Table 4. 5-8F or 6-10B cells were injected subcutaneously into
nude mice to produce tumours. Around 1 10
7 tumour cells were
injected per animal. Volumes of tumours were measured using a
slide calliper, with the volume calculated by the following formula
(Hazama et al, 1999): a b
2/2, where ‘a’ is the larger and ‘b’ is the
smaller of the two dimensions.
Groups 1 and 2 were injected via tail vein with saline, while
groups 3 and 4 were injected with berberine (200mgkg
 1day
 1)
(Xin et al, 2005; Shu et al, 2006). Nude mice were treated for 7 days
before the injection with 5-8F and 6-10B cells. Animal weight and
tumour growth were monitored once a week. Four weeks later,
mice were killed for implanting tumour tissues preparations. The
volume of implanted tumours and body weights of mice were
measured to evaluate whether cachexia existed or not.
Statistical analysis methods
The significance of differences among different measuring
indicators was determined with the Student’s t-test (for normally
distributed data), or the Mann–Whitney U-test (for nonnormally
distributed data). Po0.05 was considered as significance. Statistics
for the gene chip data was performed by Spotfire 8.0.
RESULTS
Microarray analysis of the differentially expressed genes
related with NPC intracranial invasion potential in the
primary focus tissues
Gene-expressing profiles of NPC tissues with or without intracra-
nial invasion have been performed three times (Figure 1). There
were 31 differentially expressed genes obtained with 8 elevated
(overexpressed equal to or more than 2-fold) and 23 down-
regulated (underexpressed equal or more than 0.5-fold, 50% of
control) in NPC tissues with intracranial invasion compared with
those without invasion (Tables 2 and 3).
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Figure 1 Analysis of the differentially expressed genes associated with
intracranial invasion in primary NPC. Note: C5-NPC group with intracranial
invasion; C1-NPC group without invasion. (A) No invading NPC tissues
hybridised atlas of Cy3 and cRNA Xpro HC-III plus labelled; (B) Intracranial
invading NPC tissues hybridised atlas of Cy3 and cRNA Xpro HC-III plus
labelled; the gene-expressing profiling was done three times for each group,
and six chips have been performed for the 20 patients. (C and D) Data
normalised scatter plot from the NPC tissue samples with intracranial
invading and those with no invasion other than the primary focus. Systemic
difference caused by the process of lab was decreased by normalising the
compared data. (E) Analysing of hybridisation scatter plot of differentially
expressive genes in the NPC tissue samples with intracranial invading
tendency and those without invasion outside the primary focus. In the
panels C, D and E showing the natural logarithm of data from two
compared groups as X-axis and Y-axis, difference of two compared groups
was judged directly by distribution tendency. The genes distributed along
451 diagonal have been equally expressed, and for those, the vertically
further to diagonal, the greater difference was shown in their differential
expression.
Table 2 Underexpressed genes (o0.5-fold) in intracranial invasive NPC
Names UniGene_IDs Descriptions
NM23 79.6 Nonmetastasis cell protein expressed in
CDC25C 656 Cell division cycle 25C
HGF 809 Hepatocyte growth factor
IL8RB 846 Interleukin 8 receptor, beta
IGFBP4 1516 Insulin-like growth factor binding protein 4
NPY 1832 Neuropeptide Y
ELN 9295 Elastin
PTEN 10712 Phosphatase and tensin homolog
GRPR 73883 Gastrin-releasing peptide receptor
APC 75081 Adenomatosis polyposis coli
EXT2 75334 Exostoses (multiple) 2
ST5 79265 Suppression of tumo rigenicity 5
CUL2 82919 Cullin 2
CKS2 83758 CDC28 protein kinase 2
PDGFRL 170040 Platelet-derived growth factor receptor-like
NEO1 90408 Neogenin homolog 1
MXI1 118630 MAX interacting protein 1
CAV2 139851 Caveolin 2
CDK9 150423 Cyclin-dependent kinase 9
BAI2 200586 Brain-specific angiogenesis inhibitor 2
RBM5 201675 RNA binding motif protein 5
TNFSF13B 270737 Tumor necrosis factor superfamily, member 13b
TFE3 274184 Transcription factor binding to IGHM enhancer 3
NPC¼nasopharyngeal carcinoma.
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sValidation of differentially expressed genes
From the above 31 differentially expressed genes, we chose three
genes that is likely to be associated with intracranial invasion of
NPC, including NM23-H1, MMP-9 and VEGF165 for validation.
NM23-H1 has been shown as a tumour metastasis suppressor in
gastric carcinoma, ovarian cancer and other cancers (Kantor et al,
1993; Freije et al, 1997; Fan et al, 2003). MMP-9 has been
demonstrated to play a key role in the invading process of
cancerous cells (Hofmann et al, 2005). Elevated VEGF165
expression might be closely associated with the metastatic
potentiality of malignant cells (Cianchi et al, 2001; Su et al,
2006). To confirm our microarray findings, we used immunohis-
tochemistry (IHC), quantitative real-time PCR and western blot to
determine the expression of NM23-H1, MMP-9 and VEGF165 in
NPC tissues with and without intracranial invasion. As shown in
Figure 2, both mRNA and protein levels of NM23-H1 are
significantly lower in NPC tissues with intracranial invasion
compared with that without invasion. Meanwhile, we found that
both mRNA and protein levels of MMP-9 and VEGF165 are
apparent higher in NPC tissues with intracranial invasion
(Figure 2).
Berberine inhibits NPC cell viability and migration
Berberine is a protoberberine alkaloid, which exists in Hydrastis
canadensis (golden seal), Phellodendron amurense, Coptis chinen-
sis, Berberis vulgaris (barberry), Berberis aquifolium (Oregon
grape) and Berberis aristata (tree turmeric) (Ikram, 1975).
Berberine has been indicated to have inhibitory effect on NPC
cells (Iizuka et al, 2000; Chan et al, 2005). We compared the effect
of berberine on cell viability via XTT in two different NPC cell
lines, an aggressive one, 5-8F and another one with lower
metastasis potential, 6-10B. Time- and dose-dependent cytotoxic
effect of berberine on the two cell lines is shown in Figures 3A and
B. The viability of berberine-treated 5-8F cells was significantly
lower than that of berberine-treated 6-10B cells. We further
investigated the effect of berberine on cell motility in 6-10B
and 5-8F cells by transwell chamber. As shown in Figure 3D, the
number of cells invaded through filters was significantly higher in
5-8F cells than that in 6-10B cells (78±4 vs 19±5%, Po0.01).
When cultured with berberine, the migration of 5-8F cells
decreased significantly, but there was no apparent change for 6-
10B cells, suggesting that berberine is more potent in suppressing
the motility of NPC with high metastasis potential than those with
low metastasis potential.
We then examined the expression of NM23-H1 in 6-10B and 5-
8F cell lines and found that the NM23-H1 level is much lower in 5-
8F cell line. It is plausible that NM23-H1 plays a role in the high
metastasis potential of 5-8F cells, and berberine may affect NPC
metastasis via NM23-H1. To test this hypothesis, we created
several hairpin loop constructs that produce siRNAs targeted
against NM23-H1 (siNM23-H1) transcripts and examined the
effect of berberine on the cell viability of 5-8F cells transfected with
those constructs and compared with that of 5-8F and 6-10B cells.
Knocking down of NM23-H1 expression with siRNA significantly
increases the viability and migration of berberine-treated 5-8F cells
(Figures 3A–D).
Our results suggest that berberine is more effective on
aggressive NPC cell line 5-8F, which has low level of NM23-H1.
In addition, our data indicate that the anti-NPC effect of berberine
is likely to depend on NM23-H1.
Berberine increases NM23-H1 activity in cells
To confirm our above observation that the anti-NPC effect of
berberine depends on NM23-H1, we evaluated the effect of
Table 3 Overexpressed genes (42-fold) in intracranial invasive NPC
tissues
Names UniGene_IDs Descriptions
IL11 1721 Tousled-like kinase1
PRDM4 21807 Cytochrome P450, subfamily IIIA
(niphedipineoxidase), polypeptide 4
MNT 25497 Adenylate cyclase 6
VEGFC 79141 Vascular endothelial growth factor C
PIM2 80205 Cysteine-rich, angiogenic inducer, 61
NAB2 159223 TXK tyrosine kinase
TPD52L2 154718 Tumor protein p53-binding protein
MMP9 2936 Matrix metalloproteinase 9
NPC¼nasopharyngeal carcinoma.
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Figure 2 Validation of NM23-H1, VEGF165 and MMP-9 expression in
the tissue samples of primary focus of NPC. (A) Validation with IHC (H&E,
 10). A1, A3, A5: NPC tissues with no invasion; A2, A4, A6: NPC tissues
with intracranial invading signs. (B) Validation by the quantitative real-time
PCR. Glyceraldehyde 3-phosphate dehydrogenase served as control.
Relative mRNA levels of NM23-H1, VEGF165 or MMP-9 mRNA/GAPDH
are expressed as the relative abundance. C1: NPC tissues with no invasion,
C5: NPC tissues with intracranial invading signs. (C) Validation with
western blot. Tissues lysates from two groups were subjected to western
immunoblotting with anti-NM23-H1, VEGF165 or MMP-9 antibody, and
blot was reprobed with anti-GAPDH to verify equal loading.
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sberberine on NM23-H1 expression in NPC cell lines by western
blot. As shown in Figure 3E, melittin increased NM23-H1 protein
level in 5-8F cells. To further verify the specific effect of berberine
on NM23-H1, we introduced siNM23-H1 into 5-8F cells and found
that siNM23-H1 reversed the inhibitory effect of berberine on cell
motility, as well as NM23-H1 activity (Figures 3D–E).
Berberine inhibits ICRAC in cells
Berberine has been indicated to have inhibitory effect on Ca
2þ
current (Wang et al, 1997; Wu et al, 1998). It is possible that
berberine affects NPC via Ca
2þ current. To prove that, we
examined the effect of berberine on ICRAC of 5-8F and 6-10B cell
lines by patch clamp. As shown in Figures 3F and G, there were no
significant changes in the values of ICRAC between 5-8F and 6-10B
cells. When treated with berberine, the current value of ICRAC in 5-
8F cells, significantly decreased from ( 1.40±0.37) nA to
( 1.28±0.34) nA, (Po0.05, see Figure 3F); but there was no
apparent change for 6-10B cells (Figure 3G).
Berberine inhibits NPC growth and metastasis in vivo
We have shown above that berberine can induce NM23-H1
expression and prevent the migration of HCC cells. We
investigated whether it could suppress HCC tumour growth and
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Figure 3 The inhibitory effect of berberine on the NPC invasion in vitro and in vivo. Cytotoxic effects of berberine on 5-8F (A), 6-10B (B) or siNM23-H1
transfected 5-8F cells (C). The cytotoxicity of berberine was evaluated using an XTT cell proliferation assay. 5 10
4 cells were cultured for 24, 48, 72 and
96h in 96-well microplates (100ml per well) with various concentration of berberine as indicated. Cell viability values (%) are expressed as means±s.e. from
four separate measurements, t-test. (D) Inhibitory effect of berberine on cell motility in 5-8F, 6-10B and siNM23-H1 transfected 5-8F cells (cultured with
2.8mgml
 1 berberine for 72h). The values (% of cells) are expressed as means±s.e. from four separate measurements, t-test, *Po0.01, 5-8F, berberine-
treated siNM23-H1-transfected 5-8F cells vs other cells. (E) Berberine increased NM23-H1protein expression in NPC cells, and siNM23-H1 is effective in
knocking down the expression of endogenesis NM23-H1. (F, G) Berberine inhibited ICRAC in NPC cells. Igor Pro 4.0 demo was used to observe and record
the effect of prolonging time on ICRAC.( H) Left panel: Berberine increased NM23-H1 expression in vivo. NM23-H1 mRNA in the implanting tumour tissues
of nude mice was shown as the relative abundance and GAPDH as control. Right panel: Berberine increased NM23-H1 protein expression in vivo. Berberine
(200mgkg
 1day
 1) was injected into different groups of nude mice with implanting tumour induced by injection of various lines of NPC cells. NM23-H1
expression level was significantly higher in the tumour tissues from animals induced with 5-8F than those with 6-10B cells.
Table 4 Comparison of the implanting tumour volumes and the body
weights among different groups treated with berberine (x ¯±s)
Groups n
Volumes
(cm
3)
Body
weights (g)
Berberine treatment
(200mgkg
 1day
 1)
NPC
cells
1 10 0.375±0.04* 23.5±0.44   5-8F
2 10 0.219±0.01 25.7±0.47   6-10B
3 10 0.206±0.03 28.3±2.59* + 5-8F
4 10 0.183±0.03 26.2±2.42 + 6-10B
NPC¼nasopharyngeal carcinoma. *Po0.01 compared with other groups.
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injecting 5-8F and 6-10B. The effect of berberine in vivo on NPC
tumour growth and NM23-H1 expression was determined by
examining implanting tumour volume and nude mice body
weights (Table 4 and Figure 3H). We found that there was a
significant decrease in tumour volumes accompanied by an
increase in body weights and NM23-H1 expression in berberine-
treated implanted tumour induced by 5-8F cells, suggesting an
inhibitory effect of berberine on NPC tumour growth and cachexia.
In addition, berberine can induce the expression of NM23-H1 in
vivo.
DISCUSSION
Intracranial invasion usually lead to poor prognosis in NPC
patients. Therefore, it is important to find out the underlying
mechanism for intracranial invasion of NPC. In this study, we used
Human Xpro HC-plus cancer-related gene chip to screen
intracranial invasion-associated genes for NPC. Several genes that
are differentially expressed between NPC with and without
intracranial invasion are identified and confirmed including
NM23-H1, MMP-9 and VEGF165. They can be used as potential
intracranial invasion-associated indicators, especially for NM23-
H1. We found that NM23-H1 expression levels are evidently lower
in NPC tissues with intracranial invasion as well as with an
aggressive NPC cell line, 5-8F, compared with NPC tissues without
intracranial invasion and a less aggressive NPC cell line, 6-10B.
Knocking down of NM23-H1 expression with RNAi significantly
inhibits the cell motility of 5-8F cells. All these evidence indicate
that NM23-H1 is an important regulator for the intracranial
invasion of NPC cells.
Berberine has been found to have anti-NPC effect and inhibits
Ca
2þ current (Wang et al, 1997; Wu et al, 1998). We demonstrate
that berberine is able to suppress cell viability, cell motility and
ICRAC of aggressive NPC cells more obviously than that of less
aggressive ones. Berberine inhibits cell motility accompanied by
induction of NM23-H1 expression. It failed to inhibit cell motility
in the siNM23-H1-transfected 5-8Fcells. In addition, berberine
could inhibit NPC implanting tumour and cachexia in vivo in nude
mouse model of human NPC. This evidence indicates that
berberine-induced NM23-H1 expression is likely to play a crucial
role in its inhibition of cell motility.
In summary, our present investigation has demonstrated that
downregulated NM23-H1 expression is very likely to be involved in
NPC intracranial invasion. Our finding that berberine can inhibit
implanting tumour and cachexia in vivo through the induction of
NM23-H1 expression, indicates that berberine is a potential drug
for NPC.
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